https://doi.org/10.1016/s0140-6736(19)31285-1
W
Walter Taylor
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
190
Papers
7.9K
Citations
44
h-index
97
i10-index
Walter Taylor is an academic researcher from Mahidol University. The author has contributed to research in topics: Malaria Research and Control & Mosquito-borne diseases and control & Hemoglobinopathies and Related Disorders. The author has an h-index of 44, co-authored 162 publications.
ORCID: 0000-0001-6236-0464Papers by this author
worksShort-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
2019 · The Lancet · 176 citations
Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia
2015 · BMC Medicine · 82 citations
https://doi.org/10.1186/s12916-015-0535-9
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
2023 · The Lancet Infectious Diseases · 37 citations
https://doi.org/10.1016/s1473-3099(23)00431-0
Prevalence and associated risk factors of soil-transmitted helminth infections in Kandahar, Afghanistan
2022 · BMC Infectious Diseases · 24 citations
https://doi.org/10.1186/s12879-022-07336-z
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
2024 · BMC Infectious Diseases · 24 citations
https://doi.org/10.1186/s12879-023-08835-3
Malaria treatment failures after artemisinin-based therapy in three expatriates: could improved manufacturer information help to decrease the risk of treatment failure ?
2006 · Malaria Journal · 20 citations
https://doi.org/10.1186/1475-2875-5-81
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat